Literature DB >> 10729938

Psychopharmacology of borderline personality disorder.

P H Soloff1.   

Abstract

Pharmacotherapy for patients with borderline personality disorder is directed against the psychobiology of cognitive-perceptual, affective, and impulsive-behavioral symptoms. A symptom-specific method using current empiric evidence for drug efficacy in each symptom domain is proposed. Drugs in each medication class have some potential utility against specific symptoms in patients with borderline personality disorder.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10729938     DOI： 10.1016/s0193-953x(05)70150-7

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN： 0193-953X


  18 in total

Review 1.  Psychopharmacology of personality disorders: review and emerging issues.

Authors:  P S Links; A Boggild; N Sarin
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

2.  Selective serotonin reuptake inhibitors in women with borderline personality disorder.

Authors:  Joachim F Hallmayer
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

Review 3.  New developments in the neurobiology of borderline personality disorder.

Authors:  Martin Bohus; Christian Schmahl; Klaus Lieb
Journal:  Curr Psychiatry Rep       Date:  2004-02       Impact factor: 5.285

4.  Self-mutilation and pharmacotherapy.

Authors:  Brian Daniel Smith
Journal:  Psychiatry (Edgmont)       Date:  2005-10

Review 5.  Functional symptoms in neurology: questions and answers.

Authors:  M Reuber; A J Mitchell; S J Howlett; H L Crimlisk; R A Grünewald
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

Review 6.  Neuroimaging in borderline personality disorder.

Authors:  Christian Schmahl; J Douglas Bremner
Journal:  J Psychiatr Res       Date:  2005-10-18       Impact factor: 4.791

Review 7.  Borderline personality disorder.

Authors:  Joel Paris
Journal:  CMAJ       Date:  2005-06-07       Impact factor: 8.262

8.  The Personality Disorders Institute/Borderline Personality Disorder Research Foundation Randomized Control Trial for Borderline Personality Disorder: reliability of Axis I and II diagnoses.

Authors:  Kenneth L Critchfield; Kenneth N Levy; John F Clarkin
Journal:  Psychiatr Q       Date:  2007-03

Review 9.  Emotion-based dispositions to rash action: positive and negative urgency.

Authors:  Melissa A Cyders; Gregory T Smith
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

10.  Borderline personality disorder: current drug treatments and future prospects.

Authors:  Bayanne Olabi; Jeremy Hall
Journal:  Ther Adv Chronic Dis       Date:  2010-03       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.